[Skip to Navigation]
Sign In
Comment & Response
January 2017

Unanswered Questions Concerning Locoregional Irradiation in Breast Cancer

Author Affiliations
  • 1Radiation Oncology Department, Hôpital Neuchâtelois, La Chaux-de-Fonds, Switzerland
JAMA Oncol. 2017;3(1):126-127. doi:10.1001/jamaoncol.2016.3412

To the Editor The 2 Viewpoints1,2 debating adjuvant locoregional radiation therapy in the setting of intermediate-risk breast cancer (patients with 1-3 positive lymph nodes,3,4 internal tumor location,3 or node negative but with high-risk features4) resume the current discussions in tumor boards following publication of these pivotal trials.3,4 However, several questions emerge.

Add or change institution